NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

IntegraGen SA (PA: ALINT)

 
ALINT Technical Analysis
5
As on 22nd Nov 2024 ALINT STOCK Price closed @ 0.44 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.01 & Strong Sell for SHORT-TERM with Stoploss of 1.38 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ALINTSTOCK Price

Open 0.45 Change Price %
High 0.45 1 Day -0.01 -2.22
Low 0.44 1 Week -0.04 -8.33
Close 0.44 1 Month -0.05 -10.20
Volume 3446 1 Year -0.90 -67.16
52 Week High 1.49 | 52 Week Low 0.46
 
PA France Most Active Stocks
ALNEV 0.00 %
FTI 5.91 -1.66%
VIEDS 0.72 4.35%
ACA 13.05 -1.66%
ATO 0.16 0.00%
ALDRV 0.00 %
ORA 10.02 1.62%
CGG 0.69 -2.82%
BNP 56.92 -2.23%
ENGI 15.39 -0.52%
 
PA France Top Gainers Stocks
MLAAH 0.02 100.00%
GNRO 0.08 33.33%
ALSAF 0.11 22.22%
ALKKO 0.11 22.22%
FINM 0.11 10.00%
FINM 0.11 10.00%
2MX 7.46 8.43%
MLIML 0.39 8.33%
ATA 0.13 8.33%
ATA 0.13 8.33%
 
PA France Top Losers Stocks
ALIMO 0.19 -40.62%
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
FPN 0.02 -33.33%
MLNMA 0.08 -20.00%
ALTBG 0.29 -14.71%
ALSAS 5.15 -12.71%
ORP 7.90 -12.03%
MLMON 0.88 -12.00%
ALCOI 3.23 -9.78%
 
 
ALINT
Daily Charts
ALINT
Intraday Charts
Whats New @
Bazaartrend
ALINT
Free Analysis
 
ALINT Important Levels Intraday
RESISTANCE0.46
RESISTANCE0.45
RESISTANCE0.45
RESISTANCE0.45
SUPPORT0.43
SUPPORT0.43
SUPPORT0.43
SUPPORT0.42
 
ALINT Forecast November 2024
4th UP Forecast0.77
3rd UP Forecast0.66
2nd UP Forecast0.6
1st UP Forecast0.53
1st DOWN Forecast0.35
2nd DOWN Forecast0.28
3rd DOWN Forecast0.22
4th DOWN Forecast0.11
 
ALINT Weekly Forecast
4th UP Forecast0.56
3rd UP Forecast0.52
2nd UP Forecast0.50
1st UP Forecast0.47
1st DOWN Forecast0.41
2nd DOWN Forecast0.38
3rd DOWN Forecast0.36
4th DOWN Forecast0.32
 
ALINT Forecast2024
4th UP Forecast2.62
3rd UP Forecast1.92
2nd UP Forecast1.49
1st UP Forecast1.06
1st DOWN Forecast-0.18
2nd DOWN Forecast-0.61
3rd DOWN Forecast-1.04
4th DOWN Forecast-1.74
 
 
ALINT Other Details
Segment EQ
Market Capital 8260198.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ALINT Address
ALINT
 
ALINT Latest News
 
Your Comments and Response on IntegraGen SA
 
ALINT Business Profile
IntegraGen SA provides human genome analysis services for academic and private laboratories in France and the United States. Its genomic services include transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. The company offers clinical research services, such as clinical grade sequencing and pharmacogenomics; basic and human genetic research; agrigenomic services, including crop and livestock genotyping and high-throughput sequencing for crops and livestock; and microbial genomics services comprising whole-genome microbial sequencing and microbial transcriptomics. It also provides MERCURY, a tool for assisting in the interpretation of exome and transcriptome data in oncology that allows biologists and pathologists to transform the data into a biological report that is used in clinical and translational research; SIRIUS, an online solution to identify genetic variants in rare diseases with mendelian transmission, or somatic variants in oncology; Galileo, a cloud-based app that allows researchers to analyze RNA data; and GeCo, a tool that provides genomic data analysis services. IntegraGen SA was founded in 2000 and is headquartered in Évry, France. Address: Genopole Campus 1 ' B't. 8, Évry, France, 91000
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service